Deenan Pillay

Best Publications

• Update of the Drug Resistance Mutations in HIV-1.

  Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard

  1980
  Citations

• 2011 update of the drug resistance mutations in HIV-1.

  Johnson Va;Calvez;Günthard Hf;Paredes R

  1246
  Citations

• Digital technologies in the public-health response to COVID-19.

  Jobie Budd;Jobie Budd;Benjamin S. Miller;Erin M. Manning;Vasileios Lampos

  1174
  Citations

• Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

  Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes

  1133
  Citations

• 2017 Update of the Drug Resistance Mutations in HIV-1.

  Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  873
  Citations

• 2014 Update of the drug resistance mutations in HIV-1.

  Annemarie M Wensing;Vincent Calvez;Huldrych F Günthard;Victoria A Johnson

  841
  Citations

• 2015 Update of the Drug Resistance Mutations in HIV-1.

  Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  766
  Citations

• Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

  Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Francoise Brun-Vezinet

  664
  Citations

• Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

  Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  492
  Citations

• Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.

  Dan Frampton;Dan Frampton;Dan Frampton;Tommy Rampling;Aidan Cross;Heather Bailey

  466
  Citations

• HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.

  Robert W. Shafer;Soo-Yon Rhee;Deenan Pillay;Veronica Miller

  430
  Citations

• Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration

  Rami Kantor;David A Katzenstein;Brad Efron;Ana Patricia Carvalho

  392
  Citations

• Drug Resistance Mutations in HIV-1.

  Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  360
  Citations

• Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

  Ravindra K Gupta;Andrew Hill;Anthony W Sawyer;Alessandro Cozzi-Lepri

  353
  Citations

• Update of the drug resistance mutations in HIV-1: March 2013.

  Victoria A Johnson;Vincent Calvez;Huldrych F Gunthard;Roger Paredes

  329
  Citations

• Taking connected mobile-health diagnostics of infectious diseases to the field

  Christopher S. Wood;Michael R. Thomas;Jobie Budd;Tivani P. Mashamba-Thompson

  321
  Citations

• Lateral flow test engineering and lessons learned from COVID-19

  Unknown

  290
  Citations

• Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

  John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers

  287
  Citations

• Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial

  Collins C Iwuji;Collins C Iwuji;Joanna Orne-Gliemann;Joseph Larmarange;Eric Balestre

  264
  Citations

• Update of the drug resistance mutations in HIV-1: 2007.

  Victoria A Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Huldrych F Günthard

  249
  Citations